4DMedical wins $1.9m funding for CT VQ clinical studies
Filed with ASX · · 3 pages · English
Summary by 6ix AI
4DMedical Ltd. has announced the receipt of significant funding for clinical studies. This funding aims to generate clinical evidence to facilitate the adoption of CT:VQ as a substitute for traditional nuclear medicine scans. The announcement highlights the potential for CT:VQ technology to disrupt the respiratory diagnostics market.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from 4DMedical
- Investor Presentation - Philips update
- 4DMedical signs Philips reseller agreement for U.S. market
- FY2024 Full year results
- Quarterly Activity Report and Appendix 4C for Q4 FY2024
- 4DMedical expands with Jones Radiology contract
Later from 4DMedical
- Quarterly Activity Report and Appendix 4C for Q1 FY2025
- 4DMedical wins 3 year commercial contract with UCSD Health
- 4DMedical wins commercial contract with IPOC
- 4DMedical signs contract to expand in Western Australia
- 4DMedical unveils CT VQ at RSNA 2024
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical